Clinical Performance of Coronavirus (COVID-19) Antigen Rapid Test Kits for the detection of COVID-19 variants in clinical nasal swabs, throat swabs, and saliva specimens from people aged 7-75 years who require COVID-19 testing

Koi Biotech Pty Ltd0 个研究点目标入组 60 人开始时间: 2023年7月27日最近更新: 2023年8月2日

试验速览

暂无简介。

•Participants must meet all the following criteria to be enrolled.
•1. Volunteer to participate in clinical research; fully understand and be able to sign the informed consent form (ICF); willing to follow and have the ability to complete all trial procedures. A signed parent/guardian PICF and assent PICF for young participants should be obtained for all young participants (younger than 18 years old). If the young participant has the capacity to read and to make the decision, a signed PICF should be obtained from the participant along with a signed parent/guardian PICF.
•2. At the time of signing the PICF, the age is 7-75 years (including the boundary values), male or female.
•3. Participants must require COVID-19 testing for their COVID-19 like symptoms on the day of testing, e.g. Fever, cough and/or sore throat, fatigue/general feeling of weakness, loss of sense of smell and/or taste, shortness of breath, muscle stiffness/body aches, head cold/running nose, etc.

•1. Patients unable to fully understand and sign the ICF are excluded;
•2. Patients with bleeding disorder are excluded from the study as a precaution;
•3. Hospitalized patients/inpatients are excluded;
•4. Application of nasal spray within 15 min prior to testing.
•5. Patients, who have COVID-19 symptoms more than 7 days prior to testing, are excluded;
•6. Eat, drink, smoke, brush your teeth, or chew gum for 10-30 minutes prior to sample collection

发起方

Koi Biotech Pty Ltd